Preparation of cabergoline

Details Preparation of cabergoline Preparation of cabergoline

2005-11-07

2008-03-04

Aulakh, Charanjit S. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S067000

Reexamination Certificate

active

07339060

ABSTRACT:
A method of preparing cabergoline Form I, comprising forming a solvate including cabergoline and a p-disubstituted benzene of formula (A) or 1,3,5-trimethylbenzene and obtaining cabergoline Form I from the solvate. Another aspect of the present invention provides a method for preparing cabergoline Form I comprising dissolving cabergoline in p-disubstituted benzene or 1,3,5-trimethylbenzene and recovering the cabergoline Form I polymorph, suitably by direct crystallization of Form I or by recovery of a solvate which can be converted to Form I. Another aspect of the present invention provides a novel cabergoline polymorph designated cabergoline Form FBand a method of preparing said polymorph by dissolving or forming a solvate of cabergoline in fluorobenzene and recovering cabergoline Form FB.

REFERENCES:
patent: 3920664 (1975-11-01), Clemens et al.
patent: 4180582 (1979-12-01), Kornfeld et al.
patent: 4202979 (1980-05-01), Kornfeld et al.
patent: 4229451 (1980-10-01), Fehr et al.
patent: 4246265 (1981-01-01), Kornfeld et al.
patent: 4526892 (1985-07-01), Salvati et al.
patent: 4675404 (1987-06-01), Bernardi et al.
patent: 4782152 (1988-11-01), Misner
patent: 5382699 (1995-01-01), Honkanen et al.
patent: 6395901 (2002-05-01), Mangia et al.
patent: 2005/0085499 (2005-04-01), Bednar et al.
patent: 2005/0245560 (2005-11-01), Greenwood et al.
patent: 535235 (1973-03-01), None
patent: 535236 (1973-03-01), None
patent: 144634 (1972-07-01), None
patent: 287176 (1999-04-01), None
patent: 1 591 455 (2005-11-01), None
patent: 2479829 (1981-10-01), None
patent: 1451724 (1976-10-01), None
patent: 1499420 (1978-02-01), None
patent: 2014140 (1979-08-01), None
patent: 0409785-3 (1991-01-01), None
patent: 2103603 (2003-09-01), None
patent: WO 01/70740 (2001-09-01), None
patent: WO 01/72746 (2001-10-01), None
patent: WO 01/72747 (2001-10-01), None
patent: WO 03/078392 (2003-09-01), None
patent: WO 03/078433 (2003-09-01), None
patent: WO 2004/094368 (2004-11-01), None
patent: WO 2004/101510 (2004-11-01), None
Candiani et al., The Ligand Effect in Copper (I)—Catalyzed Chermoselective Amide, 605-606 (1995).
Sabatino et al., X-Ray Crystal Structure and Conformational Analysis of Cabergoline . . . , II Farmaco, 50(3): 175-178 (1995).
Brambilla et al., Synthesis and Nidation Inhibitory Activity . . . , New Eur. J. Med. Chem., 24: 421-426 (1989).
Montegani et al., Synthesis of Tritium and Carbon-14 Labeled N . . . , J. Labelled Compd. Radiopharm. 29(5): 519-533 (1991).
Ohno et al., Synthesis and Structure . . . , Chem. Pharm. Bull., 42(7): 1463-1473 (1994).
Battaglia et al., Dispostion . . . , Xenobiotica 23(12): 1377-1389 (1993).
Benes et al., Epimerization of Esters of Stereoisomeric . . . , Coll. Czech. chem. Commun. 48: 1333-1340 (1983).
Stoll et al., Die Dihydroderivate der Rechtscdrehenden . . . , Helv. Chim. Acta 29(3): 635-653 (1946).
Stadler, Eine Einfache Veresterungsmethode im Eintopf-Verfahren, Helv. Chim. Acta 61(5): 1675-1681 (1978).
Fehr et al., Demthylierung des Lysergsauregerustes, Helv. Chim. Acta 53(8): 2197-2201 (1970).
Krepelka et al., Some 6-Alkyl Derivatives of D-8-Cyanomethyl . . . , Coll. Czech. Chem. Commun. 42: 1209-1215 (1977).
Jacobs et al., Isomeric Dihydrolysergic Acids and the Structure of Lysergic Acid, J. Biol. Chem. 227-239 (1936).
Cerney et al., Mutterkornalkaloide, Pharmazie 26(12) 740-741 (1971).
Kornfield et al., The Total Synthesis of Lysergic Acid, J. Am. Chem. Soc. 3087-3114 (1956).
Zhang et al., Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 6(1): 70-72 (1984).
Kleeman et al., Pharmaceutical Substances, 4th Ed., 312-313.
Dollery et al., Therapeutic Drugs, 2nd Ed., C1-C4 (1999).
Parfitt, The Pharmaceutical Press, Martindale, 32nd Ed. 1135-1136 (1999).
Gottwald et al., Ann. Pharmacother. 31: 1205-1217 (1997).
Wiseman et al., Cabergoline—A Review of its Efficacy in the Treatment of Parkinson's Disease, CNS Drugs 12 (6): 485-497 (1999).
Ichikawa et al., Nippon Yakurigaku Zasshi 117: 395-400 (2001).
The Merck Index, 13th Ed., 270 (2001).
Gotor, Non-Conventional Hydrolase Chemistry: Amide and Carbamate Bond Formation Catalyzed by Lipases, Bioorg. Med. Chem. 7: 2189-2197 (1999).
Crider et al., Convenient Synthesis of 6-Nor-9,10-Dihydrolysergic Acid Methyl Ester, J. Pharm Sci. 70 (12): 1319-1321 (1981).
Olofson et al., A New Reagent for the Selective, High Yield N-Dealkylation of Tertiary Amines . . . , J. Org. Chem. 49: 2081-2082 (1984).
Olofson et al., Tests of a Piperidino Mask for the Protection of Functionalized Carbon Sites in Multistep Syntheses, J. Org. Chem. 49: 2795-2799 (1984).
Allievi et al., Quantitative Determination of Cabergoline in Human Plasma . . . , Rapid Commun. Mass Spectrom. 12: 33-39 (1998).
Prelog et al., Helv. Chim. Acta 39: 498-504 (1956).
Vaughan, Acylalkylcarbonates as Acylating Agents for the Synthesis of Peptides, J. Am. Chem. Soc., 73: 3547 (1951).
Walker, The Functional Gropu Selectivity of Complex Hydride Reducing Agents, Chem. Soc. Rev. 5: 23-51 (1976).
Kornet et al., The Borane Reduction of Amido Esters, J. Org. Chem. 33(9): 3637-3639 (1968).
Lalancette et al., Reductions of Functional Groups with Sulfurated Borohydrides, Synthesis 526-532 (1972).
Cainelli et al. Farmaco, Ed. Sci. 22(6): 456-462 (1967).
Larock, Comprehensive Organic Transformations, 2nd Ed., Wiley VCH 1940-1977 (1999).
Humphrey et al., Chemical Synthesis of Natural Product Peptides: Coupling Methods for the Incorporation of Noncoded Amino Acids into Peptides, Chem. Rev. 97: 2243-2266 (1997).
Carpino et al., Racemization Studies During Solid-Phase Peptide Synthesis Using Azabenzotriazole-Based Coupling Reagents, Tetrahedron Lett. 35(15): 2279-2282 (1994).
Spetzler et al., Novel Acylation Catalysts in Peptide Synthesis . . . , J. Chem. Soc., Perkin Trans. 1: 1727-1731 (1998).
Gibson et al., Bis[[4-(2,2-dimethyl-1,3-dioxolyl)]methyl]-carbodiimide (BDDC) . . . , J. Org. Chem. 59: 7503-7507 (1994).
Gibson et al., Carboxy Terminus Coupling 1,1′-Carbonylbis(3-methylimidazolium triflate) (CBMIT) in the Presence of Cu(II) Salts, J. Org. Chem. 60: 2615-2617 (1995).
Soledad De Castro et al., Lipase-Catalyzed Synthesis of Chiral Amides . . . , Tetrahedron 54 2877-2892 (1998).
Sanchez et al., Candida Antarctica Lipase-Catalyzed Double Enantioselective Aminolysis Reactions, J. Org. Chem. 64: 1464-1470 (1999).
Stepanov, Proteinases as Catalysts in Peptide Synthesis, Pure and Applied Chem. 68(6) 1335-1339 (1996).
Marzoni et al., 6-Methylergoline-8-Carboxylic Acid Esters as Serotonin Antagonists, J. Med. Chem. 30: 1823-1826.
Co-Pending U.S. Appl. No. 11/100,934, entitled “Preparation of Cabergoline,” Bhatarah et al.
Co-Pending U.S. Appl. No. (To be assigned), entitled “Production of Cabergoline and Novel Polymorphic Form Thereof,” Greenwood et al.
Caira, M.R., “Crystalline Polymorphism of Organic Compounds,” Topics in Current Chemistry 198:164-207 (1998).
Search report for corresponding Great Britain Appl. No. GB 0515430.7, dated Nov. 16, 2005.
International Search Report for corresponding International Application No. PCT/GB2006/002784, dated Jan. 12, 2006.

Affiliated with

Also associated with

Rating

Preparation of cabergoline does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preparation of cabergoline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of cabergoline will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3967517